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background: Renal denervation (RDN) is a promising treatment for hypertension. Up to now, the effect of RDN on hard endpoints is unknown. As 
an intermediate hard endpoint we investigated the effect on left ventricular hypertrophy (LVH) assessed by cardiac magnetic resonance imaging 
(cMRI). cMRI was used since this modality has a higher accuracy and reproducibility than echocardiography in evaluation of LV-mass.
methods: Patients underwent cMRI before and 1 year after RDN. Body surface area-corrected myocardial mass was quantified by end-diastolic 
contour tracing on short axis balanced steady state free precession. Left ventricular trabeculae were included in myocardial mass. To assess the 
effect of RDN on blood pressure (BP), 24-h ambulatory blood pressure measurements (ABPM) at 1 year follow-up were compared to baseline values.
results: At moment of submission, 31 patients (18 male) were included with a mean age of 57 ±11 yrs; using a median number of 4 different 
antihypertensive drugs. Mean ambulatory systolic BP (SBP) changed from 164 ±22 mmHg to 154 ±24 mmHg (p=0.02). Overall, no statistical 
significant change in LV-mass was observed at follow-up (-2.4 ± 11.7% (-5.0 ±24.7 g/m2; absolute range: -99 to +42g/m2); p=0.27). However, in 
the subgroup of patients with a reduction of 24-h ambulatory SBP of ≥5 mmHg, a trend in decrease of LV-mass was observed (-7.8 ± 13.0% (-14.8 
±28.5 g/m2; absolute range: -99 to +10g); p=0.063).
conclusions: The current study shows no prominent change in LV-mass one year after treatment with RDN, as assessed with MRI. However, in the 
patients with a proven BP effect after RDN, the amount of decrease in LV-mass is comparable to the effect observed in studies with beta-blockers or 
diuretics. Although a larger group of patients is needed before definite conclusions can be drawn, current results are promising.
